Mucopolysaccharidosis type II

Search Trials
Extension of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase (IT)in Conjunction With Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Status:
Active, not recruiting
Last Changed:
Jan 1, 1970
First Changed:
Sep 1, 2012
Disease(s):
Hunter Syndrome
Intervention(s):
Idursulfase-IT
Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 10, 2003
Disease(s):
Mucopolysaccharidosis II
Intervention(s):
Iduronate-2-sulfatase enzyme replacement therapyiduronate-2-sulfatase enzyme replacement therapyPlacebo
Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Hunter Syndrome
Intervention(s):
Neurobehavioral testingVisual and auditory assessments
Study of Idursulfase-beta (GC1111) in Hunter Syndrome
Status:
Not yet recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Mucopolysaccharidosis II
Intervention(s):
idursulfase betaidursulfase
An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients
Status:
Completed
Last Changed:
Sep 1, 2019
First Changed:
Jan 1, 1970
Disease(s):
Hunter Syndrome
Intervention(s):
Idursulfase

Connect. Empower. Inspire.